Lately, it appears some biotech VCs have hit a ceiling, capping their new funds at or below the amount of their previous vehicles, says Paul Bonanos on the latest BioCentury This Week. Bonanos and his BioCentury editorial colleagues discuss what’s behind the trend as they assess VC fundraising in this post-‘supercycle’ era. The editors also evaluate the state of play for venture-backed obesity plays and which VCs are active in the space, as well as takeaways from the latest BioCentury Show podcast featuring Aoife Brennan, CEO of Climb Bio. Finally, the team features the new book from long-time biotech executive and current SV Health Investors partner Tim Harris, In Pursuit of Unicorns: A Journey through 50 Years of Biotechnology.
00:00 - Introduction 02:08 - Trends in VC Funds 12:16 - Obesity Start-ups 19:46 - The BioCentury Show with Aoife Brennan 26:50 - Tim Harris' New Book: In Pursuit of Unicorns
To submit a question to BioCentury’s editors, email the BioCentury This Week team at podcasts@biocentury.com.
Podden och tillhörande omslagsbild på den här sidan tillhör BioCentury. Innehållet i podden är skapat av BioCentury och inte av, eller tillsammans med, Poddtoppen.
